Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:pitavastatin
|
| gptkbp:approvedBy |
gptkb:Japan
2003 |
| gptkbp:ATCCode |
gptkb:C10AA08
|
| gptkbp:CASNumber |
147511-69-1
|
| gptkbp:developedBy |
Kowa Company
|
| gptkbp:drugClass |
statin
|
| gptkbp:hasMolecularFormula |
C50H46CaF2N2O8
|
| https://www.w3.org/2000/01/rdf-schema#label |
NK-104
|
| gptkbp:marketedAs |
gptkb:Livazo
gptkb:Livalo Zypitamag |
| gptkbp:mechanismOfAction |
HMG-CoA reductase inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
liver enzyme abnormalities
myalgia |
| gptkbp:usedFor |
treatment of hypercholesterolemia
|
| gptkbp:bfsParent |
gptkb:Pitavastatin
gptkb:pitavastatin |
| gptkbp:bfsLayer |
8
|